|
C10ORF28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10230047312143E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.50090004050696E-09 |
| Normal-vs-Stage2 |
1.1251000000545E-06 |
| Normal-vs-Stage3 |
2.56750000149353E-08 |
| Normal-vs-Stage4 |
1.66680003133024E-09 |
| Stage1-vs-Stage2 |
2.315600E-01 |
| Stage1-vs-Stage3 |
4.495600E-01 |
| Stage1-vs-Stage4 |
6.404300E-02 |
| Stage2-vs-Stage3 |
4.645200E-01 |
| Stage2-vs-Stage4 |
8.095000E-01 |
| Stage3-vs-Stage4 |
2.470000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21009999190613E-09 |
| Normal-vs-AfricanAmerican |
6.392400E-04 |
| Normal-vs-Asian |
4.74809999995163E-06 |
| Caucasian-vs-AfricanAmerican |
6.016400E-01 |
| Caucasian-vs-Asian |
2.373600E-01 |
| AfricanAmerican-vs-Asian |
8.835800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1880999995515E-07 |
| Normal-vs-Female |
6.29739593804857E-11 |
| Male-vs-Female |
2.007400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.08339999696605E-08 |
| Normal-vs-Age(41-60Yrs) |
1.68850000648035E-09 |
| Normal-vs-Age(61-80Yrs) |
8.07109999945155E-08 |
| Normal-vs-Age(81-100Yrs) |
2.371800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.143800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.397800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.244400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.729600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.409600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.352600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.820500E-02 |
| Classical-VS-Follicular |
1.682430E-01 |
| Classical-VS-Other |
7.317600E-01 |
| Classical-VS-Normal |
4.53439952252666E-10 |
| Tall-VS-Follicular |
4.151800E-01 |
| Tall-VS-Other |
4.249200E-01 |
| Tall-VS-Normal |
1.6128000046578E-09 |
| Follicular-VS-Other |
8.439200E-01 |
| Follicular-VS-Normal |
1.15730000027625E-07 |
| Other-VS-Normal |
1.275860E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.72379996335559E-09 |
| Normal-vs-N1 |
8.7631002454458E-10 |
| N0-vs-N1 |
1.091440E-01 |
|
|
